DRÄGERWERK AG & CO. KGAA Financials Drägerwerk AG & Co. KGaA Xetra
Equities
DRW8
DE0005550602
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.4 EUR | +1.60% |
|
+1.60% | -0.67% |
| 05-01 | DRÄGERWERK AG & CO KGAA : China weighs on Q1 24 growth |  |
| 04-29 | DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating | ZD |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 823 | 1,141 | 1,020 | 723.3 | 899.6 | 881.1 | - | - |
| Enterprise Value (EV) 1 | 911.7 | 1,328 | 995.9 | 982.5 | 1,097 | 1,006 | 1,058 | 783.4 |
| P/E ratio | 38.7 x | 6.13 x | 7.68 x | -12.2 x | 8.84 x | 9.04 x | 8.63 x | 6.11 x |
| Yield | 0.34% | 0.3% | 0.34% | 0.46% | 3.36% | 3.48% | 2.23% | 4.68% |
| Capitalization / Revenue | 0.3 x | 0.33 x | 0.31 x | 0.24 x | 0.27 x | 0.25 x | 0.24 x | 0.24 x |
| EV / Revenue | 0.33 x | 0.39 x | 0.3 x | 0.32 x | 0.33 x | 0.29 x | 0.29 x | 0.21 x |
| EV / EBITDA | 4.7 x | 2.55 x | 2.37 x | 17.6 x | 3.48 x | 3.11 x | 3.13 x | 1.9 x |
| EV / FCF | 8.9 x | 3.85 x | 3.63 x | -9.15 x | 8.97 x | 9.95 x | 8.99 x | 4.48 x |
| FCF Yield | 11.2% | 26% | 27.6% | -10.9% | 11.1% | 10% | 11.1% | 22.3% |
| Price to Book | 0.92 x | - | 0.82 x | 0.59 x | 0.69 x | 0.64 x | 0.6 x | - |
| Nbr of stocks (in thousands) | 17,712 | 18,655 | 18,671 | 18,651 | 18,760 | 18,760 | - | - |
| Reference price 2 | 55.70 | 62.80 | 55.25 | 41.75 | 51.80 | 50.00 | 50.00 | 50.00 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 16/03/23 | 07/03/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,781 | 3,406 | 3,328 | 3,045 | 3,374 | 3,460 | 3,611 | 3,730 |
| EBITDA 1 | 193.8 | 521 | 421 | 55.8 | 315 | 323 | 338.6 | 412 |
| EBIT 1 | 66.58 | 396.6 | 271.7 | -88.61 | 166.4 | 160.2 | 181.3 | 226.9 |
| Operating Margin | 2.39% | 11.64% | 8.16% | -2.91% | 4.93% | 4.63% | 5.02% | 6.08% |
| Earnings before Tax (EBT) 1 | 49.53 | 360.2 | 236.6 | -102.4 | 141.3 | 150.3 | 159.7 | 221.6 |
| Net income 1 | 33.35 | 250.2 | 154.2 | -64.56 | 110.4 | 103.7 | 108.6 | 153.6 |
| Net margin | 1.2% | 7.34% | 4.63% | -2.12% | 3.27% | 3% | 3.01% | 4.12% |
| EPS 2 | 1.440 | 10.25 | 7.190 | -3.410 | 5.860 | 5.530 | 5.793 | 8.190 |
| Free Cash Flow 1 | 102.4 | 345 | 274.5 | -107.4 | 122.3 | 101.1 | 117.8 | 174.7 |
| FCF margin | 3.68% | 10.13% | 8.25% | -3.53% | 3.63% | 2.92% | 3.26% | 4.68% |
| FCF Conversion (EBITDA) | 52.84% | 66.23% | 65.21% | - | 38.83% | 31.3% | 34.78% | 42.4% |
| FCF Conversion (Net income) | 307.05% | 137.93% | 178.01% | - | 110.75% | 97.49% | 108.44% | 113.74% |
| Dividend per Share 2 | 0.1900 | 0.1900 | 0.1900 | 0.1900 | 1.740 | 1.740 | 1.117 | 2.340 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 16/03/23 | 07/03/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2024 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,428 | 1,633 | 649.5 | 652.9 | 1,302 | - | 761.1 | 771.3 | 1,532 | 788.5 | 780.8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 101.6 | 209.2 | - | -76.61 | -111.7 | - | - | - | - | - | 28.3 |
| Operating Margin | 7.11% | 12.81% | - | -11.73% | -8.58% | - | - | - | - | - | 3.62% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | -26.91 | - | - | - | 17.04 | 10.72 | 27.75 | - | - |
| Net margin | - | - | -4.14% | - | - | - | 2.24% | 1.39% | 1.81% | - | - |
| EPS | - | - | - | - | - | -1.860 | - | 0.5700 | 1.470 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 13/08/20 | 29/07/21 | 28/04/22 | 28/07/22 | 28/07/22 | 27/10/22 | 28/04/23 | 27/07/23 | 27/07/23 | 02/11/23 | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 88.7 | 187 | - | 259 | 198 | 125 | 177 | - |
| Net Cash position 1 | - | - | 24 | - | - | - | - | 97.7 |
| Leverage (Debt/EBITDA) | 0.4577 x | 0.3591 x | - | 4.645 x | 0.6276 x | 0.3866 x | 0.5234 x | - |
| Free Cash Flow 1 | 102 | 345 | 275 | -107 | 122 | 101 | 118 | 175 |
| ROE (net income / shareholders' equity) | 3.1% | 23.7% | 13.5% | -5.01% | 8.11% | 7% | 7% | 9.1% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 60.50 | - | 67.20 | 70.30 | 75.00 | 78.50 | 83.50 | - |
| Cash Flow per Share | 7.080 | - | - | - | - | - | - | - |
| Capex 1 | 58.5 | 115 | 110 | - | 68.2 | 80 | 100 | 106 |
| Capex / Sales | 2.1% | 3.37% | 3.32% | - | 2.02% | 2.31% | 2.77% | 2.83% |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 16/03/23 | 07/03/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
50
EUR
Average target price
57.5
EUR
Spread / Average Target
+15.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.84% | 218B | |
| +7.35% | 183B | |
| +13.04% | 134B | |
| +26.03% | 106B | |
| -1.33% | 61.12B | |
| +4.81% | 50.89B | |
| +0.30% | 40.3B | |
| +2.78% | 35.53B | |
| +26.14% | 32.05B |
- Stock Market
- Equities
- DRW3 Stock
- DRW8 Stock
- Financials Drägerwerk AG & Co. KGaA
